Skip to content
Home » Pharmaceutical » JNJ » Page 4

JNJ

pexels-photo-5922067.jpeg

JNJ COVID-19 vaccine receives FDA emergency use authorization – great news

On 26 February 2020, the Johnson and Johnson (JNJ) COVID-19 vaccine underwent an FDA expert review, similar to the ones for the Pfizer and Moderna COVID-19 vaccines. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously in favor of the third vaccine in the USA to prevent COVID-19. On 27 February 2020, the USFDA gave clearance for an Emergency Use Authorization (EUA).

VRBPAC agreed that the vaccine was very effective, especially in preventing death and serious COVID-19 disease. They also found no serious safety signals, with the incidence serious adverse events were no higher compared to the placebo group or what would be expected in the general population.

The EUA approved the vaccine for use in adults 18 and older. Before JNJ can ship the vaccine, the CDC’s Advisory Committee on Immunization Practices (ACIP) will meet tomorrow to make recommendations on who can receive this vaccine.

Read More »JNJ COVID-19 vaccine receives FDA emergency use authorization – great news
pexels-photo-5878514.jpeg

Johnson and Johnson COVID-19 vaccine scientific facts

On 26 February 2020, the Johnson and Johnson (JNJ) COVID-19 vaccine underwent an FDA expert review, similar to the ones for the Pfizer and Moderna COVID-19 vaccines. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously in favor of the third vaccine in the USA to prevent COVID-19. This vote by the vaccine experts is the last step in advance of FDA clearance for an Emergency Use Authorization (EUA).

This article will review the key points about the Johnson and Johnson COVID-19 vaccine’s safety, effectiveness, ingredients, and other critical information. This scientific information should answer a lot of questions about the vaccine that will inevitably arise over the next few weeks.

This will be different than my myth debunking article (which will be constantly updated as the anti-vaxxers get going with their lies and disinformation), as this article will try to make sure that everyone is on the same page with what this vaccine is. 

Read More »Johnson and Johnson COVID-19 vaccine scientific facts
JNJ COVID-19 vaccine

JNJ seeking emergency use authorization for its COVID-19 vaccine

Pharmaceutical giant Johnson and Johnson (JNJ) has submitted an application for an emergency use authorization (EUA) for its COVID-19 vaccine. In phase 3 clinical trials, results showed that it was effective against the illness, and it was especially robust in preventing severe cases of COVID-19 along with death.

The COVID-19 vaccine, which was developed by JNJ subsidiary Janssen Biotech, will be reviewed by an FDA advisory committee on 26 February 2021. If that review goes well, the FDA Commissioner could issue the EUA within a few days.

Read More »JNJ seeking emergency use authorization for its COVID-19 vaccine
COVID-19 vaccines rushed

COVID-19 vaccines rushed? Another anti-vaccine myth without merit

One of the enduring myths about vaccines is that they’re rushed to market, which has continued with COVID-19 vaccines. This myth doesn’t arise because the anti-vaxxers have some “gotcha” information about these vaccines, it’s because they are intent on pushing fear, uncertainty, and doubt.

If you read my articles since March about the development of this vaccine, I was very troubled about the speed of development. Most vaccines take 5-10 years to develop, mostly because we want a better handle on the expected effectiveness and to uncover any potential (and extremely rare) serious adverse events.

But were the COVID-19 vaccine rushed? Not really. Basically, two massive resources – money and brainpower – were thrown at developing a vaccine so that we could stop the inexorable march of the pandemic. The best scientists in the world collaborated with the best pharmaceutical companies with the backing of the richest countries to develop and manufacture safe and effective vaccines.

It wasn’t a magical process where scientists pulled ideas out of thin air to make these vaccines using dangerous technologies. They didn’t.

We know how to train the adaptive immune system to prevent pathogenic diseases with vaccines using all kinds of technologies. Once we were able to isolate the SARS-CoV-2 virus and determine what parts of its structure were the most immunogenic, we knew what to do, it wasn’t a huge mystery at that time.

Read More »COVID-19 vaccines rushed? Another anti-vaccine myth without merit

COVID-19 vaccine candidates

COVID-19 vaccine candidates in phase 3 clinical trials – the official list

Keeping up with COVID-19 vaccine candidates in clinical trials has gotten out of hand, so keeping up with these clinical trials have become almost impossible. For brevity, I have made the editorial decision to update this list to include just those vaccines in phase 3 clinical trials, which means that they are within the final stages of clinical assessment.

Recently, the World Health Organization (WHO) has listed over 200 COVID19 vaccine candidates, which is amazing, but it is still too difficult to tell which ones will be successful or not without reviewing the actual data. Just because it’s in a phase 3 trial does not mean it will work.

Right now, there are nearly 50 COVID-19 vaccine candidates in phase 1, 2, or 3 clinical trials – this article will only focus on those in phase 3.

Read More »COVID-19 vaccine candidates in phase 3 clinical trials – the official list